Stockreport

VYNE Therapeutics to Participate in March Investor Conferences

VYNE Therapeutics Inc.  (VYNE) 
PDF BRIDGEWATER, N.J., Feb. 20, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focuse [Read more]